Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 04.07.2022.

#NBTNewsBeat
#Alzheimers
#stocks
#biotech
#iniziomedical
#scientific
#medcomms
#Inizio

@NatureBiotech shared
On Jul 1, 2022
"We join the resounding millions in chorus to express our profound dismay and disappointment at the US Supreme Court’s decision": An open letter from female biotech leaders on post-Roe America #NBTNewsBeat https://t.co/FVIP3M22sB
Open
An Open Letter from Female Biotech Leaders on Post-Roe America

An Open Letter from Female Biotech Leaders on Post-Roe America

[Editor’s Note: this letter was drafted by female biotech leaders in response to the Supreme Court’s Dobbs decision. It was co-signed by more than 65 female biotech executives as of July 1. ...

@SWLifeSciences shared
On Jul 1, 2022
"We view PMN310 as potentially representing a best-in-class opportunity," noted an Argus Research Co. report. Trial of New Alzheimer's Drug Slated for Early 2023: https://t.co/hkJTgGV0IX $PMN:TSX $ARFXF #Alzheimers #biotech #stocks @ProMISinc
Open
Trial of New Alzheimer's Drug Slated for Early 2023 Research Report

Trial of New Alzheimer's Drug Slated for Early 2023 Research Report

The biotech behind this product candidate differentiates itself from competitors with its approach to developing selective antibody therapies, noted an Argus Re

@ldtimmerman shared
On Jun 28, 2022
How Grace Science built a community into a company. By @VentureValkyrie https://t.co/p9DImqNDGA
Open
How Grace Science Built a Community Into a Company

How Grace Science Built a Community Into a Company

Matt Wilsey, CEO of Grace Science, once said, “You may have a plan set out for your career and your family, but life doesn’t always turn out that way…you have to make the most of it…turn ...

@MEDiSTRAVA_Cons shared
On Jun 30, 2022
Something exciting has been happening... MEDiSTRAVA Consulting is now an #Inizio Medical company! Made to advance #scientific understanding and partnerships to take on challenges & break from convention. Visit Inzio's new website https://t.co/cY2KfUe35j #iniziomedical #medcomms https://t.co/4m7zmRpx3I
Open
Welcome to Inizio.

Welcome to Inizio.

Inizio is a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engagement services throughout the drug lifecycle.

@BIODeutschland shared
On Jul 1, 2022
Dr. Falk Pharma and Zedira announce start of the phase 2a proof of concept study of ZED1227 for the treatment of non-alcoholic fatty liver disease (NAFLD) https://t.co/XYwqB86wZg
Open
Dr. Falk Pharma and Zedira announce start of the phase 2a proof of concept study of ZED1227 for the treatment of non-alcoholic fatty liver disease (NAFLD)

Dr. Falk Pharma and Zedira announce start of the phase 2a proof of concept study of ZED1227 for the treatment of non-alcoholic fatty liver disease (NAFLD)

Freiburg and Darmstadt, July 1st, 2022 Dr. Falk Pharma GmbH and Zedira GmbH are announcing the start of a phase 2a clinical trial of tissue transglutaminase inhibitor ZED1227 in …

Read more:
weekly 04.07.2022
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy